Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three- Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile Delivery by Drug-Loaded Matrix Tablets

Author(s): Giuseppina Campisi, Libero Italo Giannola, Alberto Fucarino, Antonella Marino Gammazza, Alessandro Pitruzzella, Vito Marciano, Viviana De Caro, Maria Gabriella Siragusa, Giulia Giandalia, Domenico Compilato, Stephen T. Holgate, Donna E. Davies, Felicia Farina, Giovanni Zummo, Carlo Paderni, Fabio Bucchieri.

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 34 , 2012

Become EABM
Become Reviewer

Abstract:

Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting sideeffects, the design of formulations for local application on malignant lesions seems to be an efficient and promising drug delivery approach.

In this study, the effect of locally applied 5-FU on cell death was evaluated both in a SCC4/HEK001 model and in a newly proposed 3D outgrowth model of oral squamous cell carcinoma (OSCC). Initially, the optimal drug dose was established by delivery of solutions containing different amounts of 5-FU. The solution containing 1% (w/v) of 5-FU resulted effective in inducing cell death with complete eradication of cell colonies.

Buccal tablets were designed to deliver 5-FU locoregionally to the cancer lesions of the oral cavity. Tablets were prepared using a drug loaded matrix of acrylic/methacrylic acid copolymer containing 1% (w/w) of 5-FU and applied on 3D outgrowths. The drug release from tablets appeared to be sufficient to induce cell death as confirmed by transmission electron microscopy and enzymatic assay (TUNEL). After 120 h of treatment, when about 90% of the drug had been discharged from the tablets into the culture environment, 5-FU caused loss of cell-cell communications and apoptotic cell death. After 192 h, a complete disaggregation of the 3D oral outgrowths and the death of all the cells was observed.

Buccal matrix tablets could be considered a promising new approach to the locoregional treatment of OSCC. Risks of systemic toxicity are avoided since very low drug doses are delivered.

Keywords: 5-Fluorouracil, Locoregional drug delivery, Oral squamous cell carcinoma, Buccal tablets, Tissue engineering, 3D oral outgrowths, malignant lesions, cell death, oral cavity, systemic toxicity.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 18
ISSUE: 34
Year: 2012
Page: [5411 - 5420]
Pages: 10
DOI: 10.2174/138161212803307536
Price: $58

Article Metrics

PDF: 16